Olafur A. Sveinsson

Rare variants with large effects provide functional insights into the pathology of migraine subtypes, with and without aura

Jens K. Boldsen, Pall I. Olason, Bjarni V. Halldórsson, 2023, Nature Genetics.

HMG-CoA reductase is a potential therapeutic target for migraine: a mendelian randomization study

M. Pirinen, T. Lehtimäki, H. Stefánsson, 2024, Scientific reports.